NASDAQ:LIFE
$2.37
(
-3.27%
)
Friday, 27th Jan 2023
aTyr Pharma Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.01 | $2.62 | Friday, 27th Jan 2023 LIFE stock ended at $2.37. This is 3.27% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 5.58% from a day low at $2.33 to a day high of $2.46. |
| 90 days | $2.00 | $2.62 | |
| 52 weeks | $2.00 | $6.62 |
Historical aTyr Pharma prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $2.46 | $2.46 | $2.33 | $2.37 | 252 334 |
| 2023-01-26 | $2.49 | $2.50 | $2.44 | $2.45 | 171 050 |
| 2023-01-25 | $2.39 | $2.50 | $2.39 | $2.49 | 75 932 |
| 2023-01-24 | $2.41 | $2.49 | $2.38 | $2.42 | 55 641 |
| 2023-01-23 | $2.42 | $2.45 | $2.39 | $2.41 | 79 578 |
| 2023-01-20 | $2.32 | $2.41 | $2.28 | $2.39 | 131 313 |
| 2023-01-19 | $2.24 | $2.30 | $2.22 | $2.28 | 208 143 |
| 2023-01-18 | $2.29 | $2.35 | $2.23 | $2.24 | 203 751 |
| 2023-01-17 | $2.33 | $2.48 | $2.27 | $2.29 | 49 142 |
| 2023-01-13 | $2.29 | $2.37 | $2.29 | $2.32 | 105 278 |
| 2023-01-12 | $2.28 | $2.31 | $2.23 | $2.29 | 206 919 |
| 2023-01-11 | $2.23 | $2.29 | $2.18 | $2.23 | 101 513 |
| 2023-01-10 | $2.38 | $2.48 | $2.15 | $2.28 | 163 928 |
| 2023-01-09 | $2.49 | $2.55 | $2.37 | $2.40 | 72 500 |
| 2023-01-06 | $2.45 | $2.57 | $2.45 | $2.50 | 97 100 |
| 2023-01-05 | $2.61 | $2.62 | $2.42 | $2.45 | 76 500 |
| 2023-01-04 | $2.33 | $2.57 | $2.25 | $2.42 | 338 650 |
| 2023-01-03 | $2.25 | $2.39 | $2.21 | $2.36 | 168 543 |
| 2022-12-30 | $2.07 | $2.19 | $2.01 | $2.19 | 237 837 |
| 2022-12-29 | $2.06 | $2.10 | $2.03 | $2.08 | 172 146 |
| 2022-12-28 | $2.09 | $2.10 | $2.01 | $2.04 | 146 055 |
| 2022-12-27 | $2.12 | $2.12 | $2.07 | $2.12 | 99 337 |
| 2022-12-23 | $2.06 | $2.14 | $2.03 | $2.14 | 82 583 |
| 2022-12-22 | $2.05 | $2.09 | $2.00 | $2.07 | 131 348 |
| 2022-12-21 | $2.15 | $2.15 | $2.02 | $2.06 | 213 810 |
| 2022-12-20 | $2.10 | $2.17 | $2.09 | $2.10 | 127 038 |
| 2022-12-19 | $2.15 | $2.20 | $2.11 | $2.15 | 65 959 |
| 2022-12-16 | $2.16 | $2.18 | $2.12 | $2.18 | 73 371 |
| 2022-12-15 | $2.21 | $2.21 | $2.15 | $2.17 | 77 673 |
| 2022-12-14 | $2.23 | $2.28 | $2.16 | $2.21 | 135 880 |
| 2022-12-13 | $2.18 | $2.29 | $2.14 | $2.22 | 104 740 |
| 2022-12-12 | $2.19 | $2.24 | $2.12 | $2.16 | 148 616 |
| 2022-12-09 | $2.15 | $2.24 | $2.11 | $2.17 | 140 499 |
| 2022-12-08 | $2.10 | $2.20 | $2.01 | $2.13 | 236 061 |
| 2022-12-07 | $2.07 | $2.09 | $2.00 | $2.02 | 104 291 |
| 2022-12-06 | $2.26 | $2.28 | $2.02 | $2.07 | 215 745 |
| 2022-12-05 | $2.30 | $2.37 | $2.25 | $2.29 | 204 392 |
| 2022-12-02 | $2.30 | $2.35 | $2.27 | $2.31 | 87 112 |
| 2022-12-01 | $2.25 | $2.49 | $2.25 | $2.28 | 242 935 |
| 2022-11-30 | $2.14 | $2.18 | $2.08 | $2.16 | 61 586 |
| 2022-11-29 | $2.14 | $2.16 | $2.08 | $2.13 | 45 091 |
| 2022-11-28 | $2.15 | $2.20 | $2.06 | $2.12 | 53 443 |
| 2022-11-25 | $2.12 | $2.15 | $2.12 | $2.15 | 56 751 |
| 2022-11-23 | $2.15 | $2.22 | $2.10 | $2.11 | 83 102 |
| 2022-11-22 | $2.15 | $2.19 | $2.09 | $2.13 | 110 647 |
| 2022-11-21 | $2.25 | $2.25 | $2.10 | $2.12 | 93 666 |
| 2022-11-18 | $2.28 | $2.32 | $2.14 | $2.21 | 76 479 |
| 2022-11-17 | $2.39 | $2.39 | $2.27 | $2.27 | 63 040 |
| 2022-11-16 | $2.49 | $2.50 | $2.38 | $2.38 | 34 571 |
| 2022-11-15 | $2.47 | $2.54 | $2.43 | $2.45 | 122 060 |
About aTyr Pharma
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and ... LIFE Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
